Screener
Intellia Therapeutics NTLA Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Intellia Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Intellia Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337952
FAQ
- What is Intellia Therapeutics's net income?
- Intellia Therapeutics (NTLA) reported net income of -$106.63M in Q2 2026.
- How has Intellia Therapeutics's net income changed year-over-year?
- Intellia Therapeutics's net income decreased by 5.3% year-over-year, from -$101.26M to -$106.63M.
- What is the long-term trend for Intellia Therapeutics's net income?
- Over 4 years (2021 to 2025), Intellia Therapeutics's net income has grown at a 11.4% compound annual growth rate (CAGR), from -$267.89M to -$412.69M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Intellia Therapeutics's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude